| |
|
|
|
|
|
|
|||
|
AR Rezaie and CT Esmon
Department of Pathology, University of Oklahoma Health Sciences Center,
Howard Hughes Medical Institute, Oklahoma City.
Protein C is a vitamin K-dependent plasma serine protease zymogen, which
upon activation, functions as an anticoagulant. Protein C activation is
catalyzed by a complex of thrombin (T) with thrombomodulin (TM). This
activation is Ca(2+)-dependent, but Ca2+ inhibits protein C activation by
thrombin alone. In most proteases, specificity is determined primarily by
the residues that lie near the scissile bond. In protein C, the P2 position
is Pro, whereas in the fibrinogen A chain, P2 is Val. We have expressed a
Pro-->Val mutant of protein C (P168V) in mammalian cells. At saturating
Ca2+, the P168V and wild-type proteins were activated by the T-TM complex
equivalently, but half maximal rates of activation were obtained at 50
mumol/L Ca2+ for wild type and approximately 5 mmol/L Ca2+ for the P168V
mutant. In the absence of TM, Ca2+ no longer inhibited the activation of
the P168V mutant. These results indicate that Pro168 influences the Ca(2+)-
dependent conformational changes in protein C that control activation.
Recently, a patient with thrombotic complications has been identified with
a Pro168-->Leu substitution. Both the P168V and the P168L mutation lead
to impaired secretion caused by retention within the cell.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1994 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||